UnknownNot Applicable

Increasing HPV Immunization Rates: The Rural Adolescent Vaccine Enterprise

United States22,000 participantsStarted 2019-06-01

Plain-language summary

The goal of this study is to engage rural primary care clinics and community organizations to test interventions designed to increase HPV vaccinations in both male and female patients aged 9-26 years.

Who can participate

Age range18 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Oregon family medicine and pediatric clinics located in rural communities that see adequate numbers of patients in the age range we are studying (age 11-17 years). Exclusion Criteria: * We will not include neonates, decisionally impaired adults, and prisoners in this study.

What they're measuring

HPV vaccine series completion

Timeframe: 3 months

Trial details

NCT IDNCT03604393

SponsorOregon Health and Science University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12

View on ClinicalTrials.gov More Human Papilloma Virus trials